OTLK logo

Outlook Therapeutics (OTLK) Long Term Debt

Annual Long Term Debt

$246.90 K
+$246.90 K+100.00%

September 30, 2024


Summary


Performance

OTLK Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKbalance sheetmetrics:

Quarterly Long Term Debt

$246.90 K
-$13.50 K-5.18%

September 1, 2024


Summary


Performance

OTLK Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

OTLK Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+100.0%-
3 y3 years-97.7%-97.7%
5 y5 years-92.8%-92.9%

OTLK Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-97.7%-100.0%-99.2%-100.0%
5 y5-year-97.7%-100.0%-99.2%-100.0%
alltimeall time-98.2%-100.0%-99.2%-100.0%

Outlook Therapeutics Long Term Debt History

DateAnnualQuarterly
Sep 2024
$246.90 K(>+9900.0%)
-
Sep 2024
-
$246.90 K(-5.2%)
Jun 2024
-
$260.40 K(>+9900.0%)
Sep 2023
$0.00(-100.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
Mar 2023
-
$0.00(-100.0%)
Dec 2022
-
$31.82 M(>+9900.0%)
Sep 2022
$4300.00(-100.0%)
$4300.00(-41.1%)
Jun 2022
-
$7300.00(-49.0%)
Mar 2022
-
$14.30 K(-99.9%)
Dec 2021
-
$9.63 M(-11.9%)
Sep 2021
$10.93 M(+1054.4%)
$10.93 M(>+9900.0%)
Jun 2021
-
$59.90 K(-62.1%)
Mar 2021
-
$157.90 K(-98.5%)
Dec 2020
-
$10.69 M(+1029.6%)
Sep 2020
$946.70 K
$946.70 K(+47.3%)
Jun 2020
-
$642.50 K(-81.5%)
Mar 2020
-
$3.47 M(-1.6%)
DateAnnualQuarterly
Dec 2019
-
$3.52 M(+3.2%)
Sep 2019
$3.42 M(-3.8%)
$3.42 M(+0.2%)
Jun 2019
-
$3.41 M(-1.6%)
Mar 2019
-
$3.46 M(-0.7%)
Dec 2018
-
$3.49 M(-1.8%)
Sep 2018
$3.55 M(-73.5%)
$3.55 M(-1.9%)
Jun 2018
-
$3.62 M(-0.5%)
Mar 2018
-
$3.64 M(+1856.2%)
Dec 2017
-
$186.00 K(-98.6%)
Sep 2017
$13.41 M(+425.0%)
$13.41 M(+6618.9%)
Jun 2017
-
$199.60 K(-9.7%)
Mar 2017
-
$221.10 K(-27.3%)
Dec 2016
-
$304.30 K(-88.1%)
Sep 2016
$2.55 M(-58.4%)
$2.55 M(-13.0%)
Jun 2016
-
$2.93 M(-12.6%)
Mar 2016
-
$3.36 M(-10.0%)
Dec 2015
-
$3.73 M(-39.2%)
Sep 2015
$6.14 M(0.0%)
$6.14 M
Sep 2014
$6.14 M
-

FAQ

  • What is Outlook Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Outlook Therapeutics?
  • What is Outlook Therapeutics annual long term debt year-on-year change?
  • What is Outlook Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Outlook Therapeutics?

What is Outlook Therapeutics annual long term debt?

The current annual long term debt of OTLK is $246.90 K

What is the all time high annual long term debt for Outlook Therapeutics?

Outlook Therapeutics all-time high annual long term debt is $13.41 M

What is Outlook Therapeutics annual long term debt year-on-year change?

Over the past year, OTLK annual long term debt has changed by +$246.90 K (+100.00%)

What is Outlook Therapeutics quarterly long term debt?

The current quarterly long term debt of OTLK is $246.90 K

What is the all time high quarterly long term debt for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly long term debt is $31.82 M